Methods of determining nucleic acid structural information
Methods of double-stranded nucleic acid sequence determination and assembly that are able to identify insertions, deletions, repeat region sizes and genomic rearrangements, for example, are disclosed herein, which can use relatively large labeled nucleic acid fragments to analyze the structure of even larger genetic regions. In some embodiments these methods involve the use of certain parameters which unexpectedly improve overall method performance. In some embodiments these methods involve sample labeling that does not result in the formation of single-stranded nucleic acid fragment labeling intermediaries.
1. A method of characterizing a first nucleic acid sample to interrogate a genomic region without compromising strand phosphodiester bond integrity, comprising:
covalently labeling a plurality of nucleic acid molecules in the first nucleic acid sample at at least one repeated motif with a first label, wherein the covalent labeling maintains integrity of the plurality of nucleic acid molecules, wherein no phosphodiester bond is broken through said covalent labeling, wherein the at least one repeated motif is a methyltransferase recognition sequence, wherein labeling is effected with a methyltransferase and a modified cofactor, wherein the genomic region is at least about 4 Mb, and wherein the labeled nucleic acid molecules have a length of at least 150 kb;
marking the plurality of nucleic acid molecules in the first nucleic acid sample with a second label, wherein the second label is distinct from the first label;
linearizing the plurality of nucleic acid molecules by passing the plurality of nucleic acid molecules into at least one nanochannel;
detecting the first label and the second label to produce patterns of the at least one repeated motif of the plurality of nucleic acid molecules;
assembling the patterns of the at least one repeated motif of the plurality of nucleic acid molecules to construct a first map of the genomic region; and
comparing the first map of the genomic region to a second map of the genomic region, wherein said second map is of a reference genome, wherein the reference genome comprises sequence information that is stored digitally, and wherein the comparing comprises in silico analysis,
wherein the at least one repeated motif has an average repeat frequency of about 7 sites to about 15 sites per 100 Kb in the genomic region and wherein the strand phosphodiester bonds of the plurality of nucleic acid molecules are intact.
2. The method of claim 1 , wherein the second label is a nonspecific nucleic acid label.
3. The method of claim 1 , wherein the modified cofactor comprises a transferable tag which becomes covalently coupled to the methyltransferase recognition sequence.
4. The method of claim 1 , wherein the modified cofactor comprises a detectable tag.
5. The method of claim 3 , wherein the transferable tag is selected form the group consisting of a fluorophore, a hapten, streptavidin, avidin, neutravidin, biotin, a stabilized reactive group a radiolabel, an electromagnetic label, an azide, Dibenzocyclooctyne (DBCO), and an alkyne.
6. The method of claim 4 , wherein the detectable tag is selected form the group consisting of a fluorophore, a hapten, streptavidin, avidin, neutravidin, biotin, a stabilized reactive group, a radiolabel, an electromagnetic label, an azide, Dibenzocyclooctyne (DBCO), and an alkyne.
7. The method of claim 1 , wherein the nucleic acid molecules correspond to at least 20 fold coverage of the genomic region.
8. The method of claim 1 , further comprising:
labeling a plurality of nucleic acid molecules in a second nucleic acid sample at the same repeated motif, wherein the labeling maintains integrity of the plurality of nucleic acid molecules;
marking the plurality of nucleic acid molecules in the second nucleic acid sample with the second label;
linearizing the plurality of nucleic acid molecules in the second nucleic acid sample by passing the plurality of nucleic acid molecules into at least one nanochannel;
detecting the first label and the second label to produce patterns of the at least one repeated motif of the plurality of nucleic acid molecules from the second nucleic acid sample; assembling the patterns of the at least one repeated motif of the plurality of nucleic acid molecules to construct a second map of the genomic region; and
comparing the first map to the second map to ascertain a similarity or difference between the first nucleic acid sample and the second nucleic acid sample.
9. The method of claim 1 , comprises assembling the patterns of the at least one repeated motif of at least 100, at least 1,000, at least 1,000 or more nucleic acid molecules.
10. A method of analyzing a nucleic acid in a genomic region for a sequence structure without compromising phosphodiester bond integrity in the nucleic acid, the method comprising the steps of
a) introducing a first label at a plurality of occurrences of a recognition site of the nucleic acid to generate a covalently-bound sequence-specific label at the plurality of occurrences of the recognition site, wherein no phosphodiester bond is broken through said introducing the first label to the nucleic acid, wherein said introducing the first label comprises contacting said nucleic acid with a molecule having methyltransferase activity, wherein the genomic region is at least about 4 Mb, and wherein the labeled nucleic acid molecules have a length of at least 150 kb;
b) labeling the nucleic acid with a second label;
c) passing the nucleic acid into a nanochannel to hold the nucleic acid in an elongated state;
d) detecting the first label to identify a pattern of the recognition site;
e) detecting the second label;
f) assembling the pattern of the recognition site of the nucleic acid to construct a first map of the genomic region; and
g) comparing the first map of the genomic region to a second map of the genomic region, wherein said second map is of a reference genome, wherein the reference genome comprises sequence information that is stored digitally, and wherein the comparing comprises in silico analysis,
wherein the plurality of occurrences of the recognition site has an average repeat frequency of about 7 sites to about 15 sites per 100 Kb in the nucleic acid and wherein the phosphodiester bonds of the nucleic acid are intact.
11. The method of claim 10 , wherein the second label is a non-sequence-specific label.
12. The method of claim 10 , wherein the nucleic acid is a double-stranded DNA molecule.
13. A method of characterizing a first nucleic acid sample to interrogate a genomic region without compromising strand phosphodiester bond integrity, comprising:
covalently labeling a plurality of nucleic acid molecules in the first nucleic acid sample at at least one repeated motif with a first label, wherein the covalent labeling maintains integrity of the plurality of nucleic acid molecules, wherein no phosphodiester bond is broken through said covalent labeling, wherein the at least one repeated motif has an average repeat frequency of about 7 sites to about 15 sites per 100 Kb in the genomic region, wherein the genomic region is at least about 4 Mb, and wherein the labeled nucleic acid molecules have a length of at least 150 kb;
marking the plurality of nucleic acid molecules in the first nucleic acid sample with a second label, wherein the second label is distinct from the first label;
linearizing the plurality of nucleic acid molecules by passing the plurality of nucleic acid molecules into at least one nanochannel;
detecting the first label and the second label to produce patterns of the at least one repeated motif of the plurality of nucleic acid molecules;
assembling the patterns of the at least one repeated motif of the plurality of nucleic acid molecules to construct a first map of the genomic region; and
comparing the first map of the genomic region to a second map of the genomic region, wherein said second map is of a reference genome, wherein the reference genome comprises sequence information that is stored digitally, and wherein the comparing comprises in silico analysis,
wherein the strand phosphodiester bonds of the plurality of nucleic acid molecules are intact.
14. The method of claim 13 , wherein the at least one repeated motif is a methyltransferase recognition sequence, and wherein labeling is effected with a methyltransferase and a modified cofactor.
15. The method of claim 14 , wherein the modified cofactor comprises a transferable tag which becomes covalently coupled to the methyltransferase recognition sequence, wherein the transferable tag is selected form the group consisting of a fluorophore, a hapten, streptavidin, avidin, neutravidin, biotin, a stabilized reactive group a radiolabel, an electromagnetic label, an azide, Dibenzocyclooctyne (DBCO), and an alkyne.
16. The method of claim 14 , wherein the modified cofactor comprises a detectable tag, wherein the detectable tag is selected form the group consisting of a fluorophore, a hapten, streptavidin, avidin, neutravidin, biotin, a stabilized reactive group, a radiolabel, an electromagnetic label, an azide, Dibenzocyclooctyne (DBCO), and an alkyne.
17. The method of claim 13 , wherein the at least one repeated motif includes at least one binding site for a binding entity selected form the group consisting of a non-cutting restriction enzyme, a zinc finger protein, an antibody, a transcription factor, a transcription activator like domain, a DNA binding protein, a polyamide, a triple helix forming oligonucleotide, and a peptide nucleic acid; and wherein labeling is effected with the binding entity.
18. The method of claim 17 , wherein the binding entity comprise at least one detectable tag selected form the group consisting of a fluorophore, a hapten, streptavidin, avidin, neutravidin, biotin, a stabilized reactive group, a radiolabel, an electromagnetic label, an azide, Dibenzocyclooctyne (DBCO), and an alkyne.
19. The method of claim 1 , further comprising selecting the at least one repeated motif to be labeled having an average repeat frequency of about 5 sites to about 35 sites per 100 Kb in the genomic region.
20. The method of claim 1 , wherein the labeled nucleic acid molecules have a length of at least 180 kb.
21. The method of claim 1 , wherein the labeling is effected with a combination of at least two methyltransferases and a modified cofactor.
22. The method of claim 21 , wherein the at least two methyltransferases are selected from the group consisting of Ml.Sapl/M2.Sapl, M.Ecal/M.BstEII, RM.Maql, RM.Sno506I, M.Smal/M.Cfr9I I MCphBI/M.Pac25I/M.TspMI/M.Xcyl I M.Xmal/M.Xvell, M.Kpnl, M.EcoRV, M.Spel, M.Nhel/M.Bmtl, M.ApaLI, M.BsaHI/M.HgiDi/M.HgiGI/M.HindV, RM.RdeGBI, M.CpeA VI/M.BstZl 71, M.Hpal, M.BamHI, M.Hincll and M.Hindll, M.MspAll, M.BbrUI/M.BloAI/M.Kasl/*M.MlaZV/M.PluTI/M.Sfol, M.Acll, M.BssSI, Ml.BsrBI/M2.BsrBI, M.BsaAI/*M.Ppu2 ll, RM.AspNLS2ORF1089P/RM.PspOMII, M.Haell/M.NgoAI/M.NgoBI, RM.RflFIII, and *M.Eco72I/M.Pm11.